Russell Investments Group Ltd. grew its stake in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 364.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 73,241 shares of the company's stock after buying an additional 57,475 shares during the period. Russell Investments Group Ltd. owned 0.12% of Guardian Pharmacy Services worth $1,484,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. R Squared Ltd purchased a new stake in Guardian Pharmacy Services during the 4th quarter worth $30,000. Investment Research & Advisory Group Inc. acquired a new position in Guardian Pharmacy Services in the 4th quarter worth $34,000. Compass Financial Services Inc acquired a new position in Guardian Pharmacy Services in the 4th quarter worth $58,000. JPMorgan Chase & Co. bought a new stake in Guardian Pharmacy Services in the fourth quarter valued at about $77,000. Finally, Quantbot Technologies LP acquired a new position in shares of Guardian Pharmacy Services in the 4th quarter worth approximately $81,000.
Wall Street Analysts Forecast Growth
Separately, Truist Financial lifted their target price on Guardian Pharmacy Services from $24.00 to $25.00 and gave the stock a "buy" rating in a research report on Friday, April 11th.
Read Our Latest Research Report on GRDN
Guardian Pharmacy Services Stock Up 0.7 %
Shares of GRDN traded up $0.17 during midday trading on Thursday, reaching $23.69. The stock had a trading volume of 13,339 shares, compared to its average volume of 151,543. Guardian Pharmacy Services, Inc. has a 52 week low of $14.16 and a 52 week high of $25.74. The firm's 50 day moving average price is $20.85 and its 200-day moving average price is $20.93.
Guardian Pharmacy Services Profile
(
Free Report)
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Further Reading
Before you consider Guardian Pharmacy Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.
While Guardian Pharmacy Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
